Roger Allen Sabbadini

Lpath Therapeutics, Inc.

$8,234,133

Attributed

$8,346,127

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY2008–14

$5M$3.8M$2.5M$1.3M$0

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$8,346,127 · 7

By mechanism

R44$4,642,264 · 3

RC3$3,000,000 · 1

R43$703,863 · 3

Top collaborators

Neil Harris1 shared

Most similar at Lpath Therapeutics, Inc.

Same institution · by research overlap

Jonathan Michael Wojciak$152,724

Others in their field

Top investigators on “Safety”

David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
Mitchell J Malone · Texas A&M Research Foundation$329,191,208
Gary D Acton · University Of California-Davis$320,373,312
Melynda Holmes · Technical Resources Inc$232,659,786
Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316

Research focus

SafetyClinical TrialsSphingosine 1-PhosphateSmall Business Innovation Research GrantGrowth FactorMalignant NeoplasmsHumanized Monoclonal AntibodiesSafety StudySphingolipidsTissuesBasePlasmaInflammationLipidsSignal TransductionNonhuman PrimateEfficacy TrialAntibodiesCommercializationGrowthMarketingDrug KineticsFundingBiomarker